Lv41
528 积分 2023-09-15 加入
All-Oral Treatment of Newly Diagnosed Acute Myeloid Leukemia
10小时前
待确认
A novel CRLF2-targeted antibody-drug conjugate exhibits potent anti-leukemic activity against Ph-like acute lymphoblastic leukemia
15天前
已完结
MM-718: Lisaftoclax (APG-2575) Combined With Novel Therapeutic Regimens in Patients With Relapsed or Refractory (R/R) Multiple Myeloma (MM) or Immunoglobulin Light-Chain (AL) Amyloidosis
1个月前
已关闭
Addition of Low-Dose Decitabine to Anti–PD-1 Antibody Camrelizumab in Relapsed/Refractory Classical Hodgkin Lymphoma
1个月前
已完结
A 2026 update on myelodysplastic neoplasms: current state, challenges and future directions
2个月前
已完结
Venetoclax plus 3 + 7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial
2个月前
已完结
Measurable Residual Disease–Guided Therapy for Chronic Lymphocytic Leukemia
2个月前
已完结
Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia
2个月前
已完结
Lisaftoclax: First Approval
2个月前
已完结
皖公网安备34019202002308
